Laura Rosiñol
Amyloidosis Foundation(US)Center for Cancer and Blood Disorders(US)Hospital Clínic de Barcelona(ES)Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(ES)Universitat de Barcelona(ES)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Cancer Treatment and Pharmacology, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma(2014)4,760 cited
- → Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group(2015)2,132 cited
- → Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma(2014)1,316 cited
- → Teclistamab in Relapsed or Refractory Multiple Myeloma(2022)1,022 cited
- → Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study(2015)836 cited
- → Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma(2013)568 cited